These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 23219272)

  • 21. Washout appearance in Gd-EOB-DTPA-enhanced MR imaging: A differentiating feature between hepatocellular carcinoma with paradoxical uptake on the hepatobiliary phase and focal nodular hyperplasia-like nodules.
    Kim JW; Lee CH; Kim SB; Park BN; Park YS; Lee J; Park CM
    J Magn Reson Imaging; 2017 Jun; 45(6):1599-1608. PubMed ID: 27726242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Focal nodular hyperplasia: intraindividual comparison of dynamic gadobenate dimeglumine- and ferucarbotran-enhanced magnetic resonance imaging.
    Marin D; Iannaccone R; Laghi A; Catalano C; Murakami T; Hori M; Kim T; Passariello R
    J Magn Reson Imaging; 2007 Apr; 25(4):775-82. PubMed ID: 17348002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contrast enhanced liver MRI in patients with primary sclerosing cholangitis: inverse appearance of focal confluent fibrosis on delayed phase MR images with hepatocyte specific versus extracellular gadolinium based contrast agents.
    Husarik DB; Gupta RT; Ringe KI; Boll DT; Merkle EM
    Acad Radiol; 2011 Dec; 18(12):1549-54. PubMed ID: 21958599
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Normal dynamic MRI enhancement patterns of the upper abdominal organs: gadoxetic acid compared with gadobutrol.
    Kühn JP; Hegenscheid K; Siegmund W; Froehlich CP; Hosten N; Puls R
    AJR Am J Roentgenol; 2009 Nov; 193(5):1318-23. PubMed ID: 19843748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MRI for characterization of benign hepatocellular tumors on hepatobiliary phase: the added value of in-phase imaging and lesion-to-liver visual signal intensity ratio.
    Lebert P; Adens-Fauquembergue M; Azahaf M; Gnemmi V; Behal H; Luciani A; Ernst O
    Eur Radiol; 2019 Nov; 29(11):5742-5751. PubMed ID: 30993437
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MR characterization of focal nodular hyperplasia: gadoxetic acid versus superparamagnetic iron oxide imaging.
    Saito K; Yoshimura N; Saguchi T; Park J; Sugimoto K; Akata S; Moriyasu F; Tokuuye K
    Magn Reson Med Sci; 2012; 11(3):163-9. PubMed ID: 23037560
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Focal nodular hyperplasia: characterisation at gadoxetic acid-enhanced MRI and diffusion-weighted MRI.
    An HS; Park HS; Kim YJ; Jung SI; Jeon HJ
    Br J Radiol; 2013 Aug; 86(1028):20130299. PubMed ID: 23873903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intrahepatic mass-forming cholangiocarcinoma: enhancement patterns on gadoxetic acid-enhanced MR images.
    Kang Y; Lee JM; Kim SH; Han JK; Choi BI
    Radiology; 2012 Sep; 264(3):751-60. PubMed ID: 22798225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simple Method for evaluating the degree of liver parenchymal enhancement in the hepatobiliary phase of gadoxetic acid-enhanced magnetic resonance imaging.
    Tamada T; Ito K; Yamamoto A; Yasokawa K; Higaki A; Kanki A; Sato T; Taniomoto D; Higashi H
    J Magn Reson Imaging; 2013 May; 37(5):1115-21. PubMed ID: 23148041
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Value of Texture Analysis on Gadoxetic Acid-Enhanced MRI for Differentiating Hepatocellular Adenoma From Focal Nodular Hyperplasia.
    Cannella R; Rangaswamy B; Minervini MI; Borhani AA; Tsung A; Furlan A
    AJR Am J Roentgenol; 2019 Mar; 212(3):538-546. PubMed ID: 30557050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differentiation of focal nodular hyperplasia and hepatocellular adenoma using qualitative and quantitative imaging features and classification and regression tree analysis.
    Alamri TM; Cerny M; Al Shaikh M; Billiard JS; Olivié D; Chagnon M; Tang A
    Abdom Radiol (NY); 2023 Mar; 48(3):874-885. PubMed ID: 36528729
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypervascular hepatocellular carcinoma 1 cm or smaller in patients with chronic liver disease: characterization with gadoxetic acid-enhanced MRI that includes diffusion-weighted imaging.
    Kim JE; Kim SH; Lee SJ; Rhim H
    AJR Am J Roentgenol; 2011 Jun; 196(6):W758-65. PubMed ID: 21606265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Typical and atypical imaging findings of intrahepatic cholangiocarcinoma using gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging.
    Kim SH; Lee CH; Kim BH; Kim WB; Yeom SK; Kim KA; Park CM
    J Comput Assist Tomogr; 2012; 36(6):704-9. PubMed ID: 23192208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Focal Nodular Hyperplasia and Hepatocellular Adenoma: Accuracy of Gadoxetic Acid-enhanced MR Imaging--A Systematic Review.
    McInnes MD; Hibbert RM; Inácio JR; Schieda N
    Radiology; 2015 Nov; 277(2):413-23. PubMed ID: 26020440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of liver cirrhosis on liver enhancement at Gd-EOB-DTPA enhanced MRI at 3 Tesla.
    Verloh N; Haimerl M; Rennert J; Müller-Wille R; Nießen C; Kirchner G; Scherer MN; Schreyer AG; Stroszczynski C; Fellner C; Wiggermann P
    Eur J Radiol; 2013 Oct; 82(10):1710-5. PubMed ID: 23806531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Focal nodular hyperplasia: hepatobiliary enhancement patterns on gadoxetic-acid contrast-enhanced MRI.
    van Kessel CS; de Boer E; ten Kate FJ; Brosens LA; Veldhuis WB; van Leeuwen MS
    Abdom Imaging; 2013 Jun; 38(3):490-501. PubMed ID: 22729462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distinguishing hypervascular pseudolesions of the liver from hypervascular hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging.
    Motosugi U; Ichikawa T; Sou H; Sano K; Tominaga L; Muhi A; Araki T
    Radiology; 2010 Jul; 256(1):151-8. PubMed ID: 20574092
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differentiating focal eosinophilic liver disease from hepatic metastases using unenhanced and gadoxetic acid-enhanced MRI.
    Kim YK; Lee YH; Kim CS; Lee MW
    Abdom Imaging; 2011 Aug; 36(4):425-32. PubMed ID: 21748468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Focal nodular hyperplasia of the liver: diffusion and perfusion MRI characteristics.
    Donati F; Boraschi P; Gigoni R; Salemi S; Falaschi F; Bartolozzi C
    Magn Reson Imaging; 2013 Jan; 31(1):10-6. PubMed ID: 22898696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differentiation of hypervascular primary hepatic tumors showing hepatobiliary hypointensity on gadoxetic acid-enhanced magnetic resonance imaging.
    Park HJ; Kim YK; Min JH; Lee J; Lee SJ; Lee ES; Ahn S
    Abdom Radiol (NY); 2019 Sep; 44(9):3115-3126. PubMed ID: 31134313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.